Experiences from tissue microarray in soft tissue sarcomas

Abstract

The tissue microarray (TMA) technology was introduced in 1998 as a tissue preserving, highthroughput technique that allows studies of multiple markers in large sample sets. TMA slides can be analyzed using techniques such as immunohistochemistry and in situ hybridization and represents a powerful tool for the investigation of potential diagnostic and prognostic markers identified in DNA microarray studies. We review the TMA method, its reproducibility, advantages, limitations and future perspectives with specific focus on soft tissue sarcomas.